EX-10.12 9 dex1012.htm SOFTGEL COMMERCIAL MANUFACTURING AND PACKAGING AGREEMENT ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 230.406....Softgel Commercial Manufacturing and Packaging Agreement • May 5th, 2020 • New Jersey
Contract Type FiledMay 5th, 2020 JurisdictionThis Softgel Commercial Manufacturing and Packaging Agreement (“Agreement”) is made this 21st day of March, 2011, by and between Catalent Pharma Solutions, LLC, a Delaware limited liability company, having a place of business at 14 Schoolhouse Road, Somerset, New Jersey 08873 (“Catalent”) and Insys Therapeutics, Inc., a Delaware corporation, having its principal place of business at 10220 S. 51st Street, Suite 2, Phoenix, AZ 85044 (“Client”).
FIRST AMENDMENT TO SOFTGEL COMMERCIAL MANUFACTURING AND PACKAGING AGREEMENTSoftgel Commercial Manufacturing and Packaging Agreement • February 27th, 2013 • Insys Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledFebruary 27th, 2013 Company IndustryThis First Amendment to Softgel Commercial Manufacturing and Packaging Agreement (this “Amendment”), is made as of this 5th day of March 2012 (“Effective Date”), by and between Catalent Pharma Solutions, LLC, a Delaware limited liability company, having a place of business at 14 Schoolhouse Road, Somerset, New Jersey 08873 (“Catalent”) and Insys Therapeutics, Inc., a Delaware corporation, having its principal place of business at 10220 S. 51st Street, Suite 2, Phoenix, AZ 85044 (“Client”).
SOFTGEL COMMERCIAL MANUFACTURING AND PACKAGING AGREEMENTSoftgel Commercial Manufacturing and Packaging Agreement • May 9th, 2011 • Insys Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
Contract Type FiledMay 9th, 2011 Company Industry JurisdictionThis Softgel Commercial Manufacturing and Packaging Agreement (“Agreement”) is made this 21st day of March, 2011, by and between Catalent Pharma Solutions, LLC, a Delaware limited liability company, having a place of business at 14 Schoolhouse Road, Somerset, New Jersey 08873 (“Catalent”) and Insys Therapeutics, Inc., a Delaware corporation, having its principal place of business at 10220 S. 51st Street, Suite 2, Phoenix, AZ 85044 (“Client”).